These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 11872661)

  • 1. Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice.
    Rabinovitch A; Suarez-Pinzon WL; Shapiro AM; Rajotte RV; Power R
    Diabetes; 2002 Mar; 51(3):638-45. PubMed ID: 11872661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
    Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
    Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
    Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
    Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly (ADP-ribose) polymerase inhibition prevents spontaneous and recurrent autoimmune diabetes in NOD mice by inducing apoptosis of islet-infiltrating leukocytes.
    Suarez-Pinzon WL; Mabley JG; Power R; Szabó C; Rabinovitch A
    Diabetes; 2003 Jul; 52(7):1683-8. PubMed ID: 12829633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with cyclosporine and interleukin-4 or interleukin-10 prolongs survival of synergeneic pancreatic islet grafts in nonobese diabetic mice: islet graft survival does not correlate with mRNA levels of type 1 or type 2 cytokines, or transforming growth factor-beta in the islet grafts.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Rajotte RV; Power RF
    Transplantation; 1997 Dec; 64(11):1525-31. PubMed ID: 9415551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death.
    Suk K; Kim S; Kim YH; Kim KA; Chang I; Yagita H; Shong M; Lee MS
    J Immunol; 2001 Apr; 166(7):4481-9. PubMed ID: 11254704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice.
    Han HS; Jun HS; Utsugi T; Yoon JW
    J Autoimmun; 1996 Jun; 9(3):331-9. PubMed ID: 8816968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testicular sertoli cells protect islet beta-cells from autoimmune destruction in NOD mice by a transforming growth factor-beta1-dependent mechanism.
    Suarez-Pinzon W; Korbutt GS; Power R; Hooton J; Rajotte RV; Rabinovitch A
    Diabetes; 2000 Nov; 49(11):1810-8. PubMed ID: 11078447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary nonfunction of islet grafts in autoimmune diabetic nonobese diabetic mice is prevented by treatment with interleukin-4 and interleukin-10.
    Faust A; Rothe H; Schade U; Lampeter E; Kolb H
    Transplantation; 1996 Sep; 62(5):648-52. PubMed ID: 8830831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen.
    Laloux V; Beaudoin L; Jeske D; Carnaud C; Lehuen A
    J Immunol; 2001 Mar; 166(6):3749-56. PubMed ID: 11238616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined therapy with interleukin-4 and interleukin-10 inhibits autoimmune diabetes recurrence in syngeneic islet-transplanted nonobese diabetic mice. Analysis of cytokine mRNA expression in the graft.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC; Power RF; Rajotte RV
    Transplantation; 1995 Aug; 60(4):368-74. PubMed ID: 7652767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene transfection and expression of transforming growth factor-beta1 in nonobese diabetic mouse islets protects beta-cells in syngeneic islet grafts from autoimmune destruction.
    Suarez-Pinzon WL; Marcoux Y; Ghahary A; Rabinovitch A
    Cell Transplant; 2002; 11(6):519-28. PubMed ID: 12428741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells.
    Augstein P; Dunger A; Heinke P; Wachlin G; Berg S; Hehmke B; Salzsieder E
    Biochem Biophys Res Commun; 2003 May; 304(2):378-84. PubMed ID: 12711326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination Therapy Using IL-2/IL-2 Monoclonal Antibody Complexes, Rapamycin, and Islet Autoantigen Peptides Increases Regulatory T Cell Frequency and Protects against Spontaneous and Induced Type 1 Diabetes in Nonobese Diabetic Mice.
    Manirarora JN; Wei CH
    J Immunol; 2015 Dec; 195(11):5203-14. PubMed ID: 26482409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets.
    Suarez-Pinzon W; Sorensen O; Bleackley RC; Elliott JF; Rajotte RV; Rabinovitch A
    Diabetes; 1999 Jan; 48(1):21-8. PubMed ID: 9892218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.
    Hancock WW; Polanski M; Zhang J; Blogg N; Weiner HL
    Am J Pathol; 1995 Nov; 147(5):1193-9. PubMed ID: 7485382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Rajotte RV; Power RF
    J Immunol; 1997 Dec; 159(12):6298-303. PubMed ID: 9550435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triptolide ameliorates autoimmune diabetes and prolongs islet graft survival in nonobese diabetic mice.
    Huang SH; Lin GJ; Chu CH; Yu JC; Chen TW; Chen YW; Chien MW; Chu CC; Sytwu HK
    Pancreas; 2013 Apr; 42(3):442-51. PubMed ID: 23146919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of cytokines in the pathogenesis and therapy of type 1 diabetes.
    Rabinovitch A; Suarez-Pinzon WL
    Cell Biochem Biophys; 2007; 48(2-3):159-63. PubMed ID: 17709885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.
    Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L
    Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.